University of Pennsylvania-allied CNS disease therapy developer Passage Bio lured contributions from investors including Lilly Asia Ventures, which also featured in its $116m series A earlier this year.

Nkarta, which is developing cell therapy treatments for cancer, has emerged from stealth with $114m in a round featuring Novo, Amgen Ventures and SR One.

Lilly Asia Ventures returned to take part in a series B round led by Access Industries unit Access Biotechnology that took Passage Bio's funding to $226m to date.

Hydrogen-fuel truck developer Nikola Corporation has received $250m in cash and services from CNH as part of a series D round expected to reach $1bn.

Legend Capital led a $100m round for social commerce platform Tongcheng Life that also featured existing backer Bertelsmann Asia Investments.

UCL and Francis Crick-founded Achilles has raised series B funding at a reported $228m valuation and will now look to advance lung cancer and melanoma treatments.

Existing backer Tencent has reportedly pulled out of a $150m contribution to a round that would have valued the online teaching service at $4.5bn, due to regulatory concerns.

Capital One and HPE-backed Thoughtspot was valued just shy of $2bn in a round that increased the total raised by the data analysis software provider to more than $550m.

Fair has collected a total of $100m in equity and debt financing from Ally Financial as part of a strategic partnership, eight months after SoftBank led its $385m series B round.

Existing investor Tencent has returned for the e-commerce company's $100m series C round, which was led by Sky9 Capital.